Navigation Links
Organogenesis Awarded a 5-Year Federal Supply Schedule Agreement with the Department of Veteran Affairs
Date:8/4/2014

ociated with chronic wounds.

With Apligraf, clinicians have a bioengineered living cell-based treatment for wounds that fail to adequately respond to conventional therapy.  Recent findings highlighting the significant burden of these debilitating chronic wounds underscore the urgent need for improved identification, prevention and aggressive treatment. [1],[2]

Diabetes affects about 1 million veterans within the VA health care system, which is nearly 20% of the patients the Department sees each year (compared to 8% of the total U.S. population).[3],[4] Diabetes is also the leading cause of blindness, end-stage renal disease, and amputation for VA patients. [5]  A recent retrospective study found that VA patients with a new diagnosis of a diabetic foot ulcer had significantly higher amputation rates compared to patients treated in adjacent private and public hospitals (6.8% private, 12% public and 23.5% VA, p< 0.001). [6]

About Apligraf
Apligraf contains two layers of human living cells: a layer of differentiated keratinocytes and a layer of fibroblasts in a collagen matrix. When placed on a wound previously unresponsive to treatment, Apligraf provides cells, collagen matrix, and other proteins, and has been demonstrated to promote healing. In controlled clinical studies, Apligraf has been shown to be an effective and safe wound care treatment, superior to conventional treatments alone.  Clinical studies of Apligraf application were based on up to 5 treatments, comprising weekly assessments and/or applications, over a 12-week period. Over 650,000 Apligraf units have been shipped for patient application.  The product is covered by Medicare, Medicaid and more than 1,500 private insurers.

About Organogenesis Inc.
Having pioneered the field, Massachusetts-based Organogenesis Inc. is a world leading regenerative medicine compa
'/>"/>

SOURCE Organogenesis Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers
2. Organogenesis Announces Annual College Scholarship Award Winner
3. NeuroPhage Awarded Second Grant from Michael J. Fox Foundation for Parkinsons Disease Research
4. Pfenex Awarded Contract For Development Of Next Generation rPA-Based Anthrax Vaccine
5. CNTS Awarded $40 Million Contract Supporting U.S. Military Through Global Public Health
6. ITRA Global’s Detroit Affiliate Awarded Contract to Manage Real Estate for Michigan’s Western and Southeastern Regions
7. Great Lakes NeuroTechnologies Awarded Patent For Sensor Based Continuous Parkinsons Assessment During Daily Activities
8. Cedar Crest College Awarded Significant Grant from the National Science Foundation
9. Faithful+Gould Joint Venture Awarded IO&T Project At Fort Detrick, MD
10. Harrisvaccines Awarded National Institute of Food and Agriculture Grant for Swine Disease Research
11. Lpath Awarded NIH SBIR Grant for Lpathomab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... (PRWEB) December 19, 2014 In contrast ... of LEDs with various colors, Valoya uses proprietary LED ... This offers best possible uniformity which is critical in ... and high spectral accuracy throughout its lifetime which is ... LED tubes. , "The investment cost was clearly ...
(Date:12/19/2014)... 2014 With only 2 weeks left ... on Sartorius Biohit products . The product specials include ... Electronic Pipette Trade-in Program, and free pipette tips. , ... around the world. They are ideal for lab technicians ... ,     Full volume range of 0.1 uL ...
(Date:12/19/2014)... , Dec. 18, 2014 Egenix, Inc. is pleased ... elected Chairman of the Board, to succeed Donald Fresne ... but will continue as a member of the Board.  In ... added to the company over almost twenty years, the Board ... Board of Directors has established a Search Committee to find ...
(Date:12/19/2014)... 2014 Relmada Therapeutics, Inc. (OTCQB: RLMD), a ... chronic pain, announced the results of its annual general ... a transformational year in Relmada,s history and it set ... said Sergio Traversa , chief executive officer of ... key financial, human resource and clinical development objectives that ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2
... countries convene in Seattle for AIDS ... Vaccine 2007 Conference, ... convene this week for the AIDS Vaccine 2007,Conference at the Sheraton ... this event has emerged as the premier forum for,the exchange of ...
... Inc. (the,"Company") (OTC Bulletin Board: TBIO) today announced financial ... financial results are,presented in the tables that follow. ... profit of $0.2 million or $0.00 per share,for the ... loss of $0.4 million or,$0.01 per share for the ...
... Inc.,(Nasdaq: RGDX ), today reported financial results ... "The second quarter of 2007 was very exciting ... offering in June," said,Kathleen Danenberg, President and CEO ... recent developments that have since been announced. During,the ...
Cached Biology Technology:Global Experts Explore Entire Spectrum of Aids Vaccine Development 2Transgenomic, Inc. Reports Second Quarter 2007 Results 2Transgenomic, Inc. Reports Second Quarter 2007 Results 3Transgenomic, Inc. Reports Second Quarter 2007 Results 4Transgenomic, Inc. Reports Second Quarter 2007 Results 5Transgenomic, Inc. Reports Second Quarter 2007 Results 6Transgenomic, Inc. Reports Second Quarter 2007 Results 7Transgenomic, Inc. Reports Second Quarter 2007 Results 8Response Genetics Reports Second Quarter 2007 Financial Results 2Response Genetics Reports Second Quarter 2007 Financial Results 3Response Genetics Reports Second Quarter 2007 Financial Results 4Response Genetics Reports Second Quarter 2007 Financial Results 5Response Genetics Reports Second Quarter 2007 Financial Results 6Response Genetics Reports Second Quarter 2007 Financial Results 7Response Genetics Reports Second Quarter 2007 Financial Results 8
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences ... monitoring, has released a new series of digital ... preclinical toxicology researchers. M series, part of the ... collect the best possible physiologic data when incorporating ... Adding functional endpoints to toxicology studies has evolved ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San ... catalyst that provides the connective tissue that enhances care ... them to easily share client-level information; earned a second ... expand to organizations serving seniors aging in community and; ... partner on December 11 th 4-6p. ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... researchers report success with transcatheter aortic valve implantation ... special form of aortic stenosis that is difficult ... of Catheterization and Cardiovascular Interventions , the ... and Interventions (SCAI), show that while all-cause mortality ...
... An international team of researchers led by Georgia State University ... of pulmonary fibrosis, a fatal disease for which there is ... human gene, CLYD, serves as a crucial negative regulator in ... to death. The research was published today in the journal ...
... BUFFALO, N.Y. -- It turns out that the milk ... example. Research by psychologists at the University at ... at least part of the reason some people are kind ... Michel Poulin, PhD, assistant professor of psychology at UB, ...
Cached Biology News:Transcatheter aortic valve implantation shows promise in patients with severe aortic stenosis 2Researchers find critical regulator to tightly control deadly pulmonary fibrosis 2Study finds peoples' niceness may reside in their genes 2
... 30 isolations. The kit provides a ... apoptotic cells from normal c lture using ... is a Ca2+-dependent phospholipid binding protein with ... Cell Isolation Kit provides a simple and ...
... diameter, 7 inch long PYREX NMR tubes are ... ground joints, valves, and vacuum racks. They are ... 300 to 500MHz. They have an O.D. of ... + 0.013-0.000mm. These NMR tubes can be used ...
Standard Fluka For microscopy (Hist.) redox indicator...
... The GenElute Gel Extraction Kit combines silica- ... or vacuum column format. DNA fragments of interest ... by solubilizing the gel. The Gel Solubilization Solution ... run in either TBE or TAE buffer. Extracted ...
Biology Products: